Donor‐type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant
Author:
Affiliation:
1. Department of HematologySingapore General Hospital Singapore
2. Blood Service Group, Health Science Authority Singapore
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15053
Reference13 articles.
1. Clinical Guide to ABO-Incompatible Allogeneic Stem Cell Transplantation
2. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature
3. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants
4. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue
5. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO‐incompatible bone marrow transplantation;Webb IJ;Biol Blood Marrow Transplant,1997
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinico-laboratory outcomes of plasma transfusion in the Egyptian’s pediatric intensive care units—a prospective observational study;Egyptian Pediatric Association Gazette;2023-11-30
2. ABO Mismatched Stem Cell Transplant and Related Complications;Basics of Hematopoietic Stem Cell Transplant;2023
3. Coagulation Management in End-Stage Liver Disease;Current Anesthesiology Reports;2022-04-20
4. Post-Hematopoietic Stem Cell Transplantation Immune-Mediated Anemia: A Literature Review and Novel Therapeutics;Blood Advances;2021-12-31
5. Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants;Annals of Hematology;2021-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3